Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2008 1
2009 8
2010 6
2011 4
2012 5
2013 5
2014 9
2015 7
2016 14
2017 6
2018 7
2019 3
2020 6
2021 12
2022 8
2023 5
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.
Babiker A, Warner S, Li X, Chishti EA, Saad E, Swihart BJ, Dekker JP, Walker M, Lawandi A, Kadri SS; NIH-Antimicrobial Resistance Outcomes Research Initiative. Babiker A, et al. Lancet Infect Dis. 2025 Mar;25(3):265-275. doi: 10.1016/S1473-3099(24)00507-3. Epub 2024 Oct 10. Lancet Infect Dis. 2025. PMID: 39396526
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, Demirkale CY, Dekker JP, Palmore TN, Rhee C, Klompas M, Hooper DC, Powers JH 3rd, Srinivasan A, Danner RL, Adjemian J; forming the National Insititutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI). Kadri SS, et al. Among authors: palmore tn. Lancet Infect Dis. 2021 Feb;21(2):241-251. doi: 10.1016/S1473-3099(20)30477-1. Epub 2020 Sep 8. Lancet Infect Dis. 2021. PMID: 32916100 Free PMC article.
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Kadri SS, et al. Among authors: palmore tn. Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378. Clin Infect Dis. 2018. PMID: 30052813 Free PMC article.
Antimicrobial Resistance.
Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Marston HD, et al. Among authors: palmore tn. JAMA. 2016 Sep 20;316(11):1193-1204. doi: 10.1001/jama.2016.11764. JAMA. 2016. PMID: 27654605
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Mikkilineni L, Yates B, Steinberg SM, Shahani SA, Molina JC, Palmore T, Lee DW, Kaplan RN, Mackall CL, Fry TJ, Gea-Banacloche J, Jerussi T, Nussenblatt V, Kochenderfer JN, Shah NN. Mikkilineni L, et al. Among authors: palmore t. Blood Adv. 2021 Dec 14;5(23):5312-5322. doi: 10.1182/bloodadvances.2021004896. Blood Adv. 2021. PMID: 34619768 Free PMC article. Review.
Isolation precautions for visitors.
Munoz-Price LS, Banach DB, Bearman G, Gould JM, Leekha S, Morgan DJ, Palmore TN, Rupp ME, Weber DJ, Wiemken TL. Munoz-Price LS, et al. Among authors: palmore tn. Infect Control Hosp Epidemiol. 2015 Jul;36(7):747-58. doi: 10.1017/ice.2015.67. Epub 2015 Apr 10. Infect Control Hosp Epidemiol. 2015. PMID: 26017347 Review. No abstract available.
99 results